HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David E Gilham Selected Research
David E Gilham Research Topics
Disease
29
Neoplasms (Cancer)
01/2020 - 06/2003
4
B-Cell Lymphoma (Lymphoma, B Cell)
10/2018 - 07/2004
2
Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 09/2013
2
Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 04/2018
2
Renal Cell Carcinoma (Grawitz Tumor)
08/2014 - 05/2008
2
Melanoma (Melanoma, Malignant)
10/2013 - 07/2008
2
Colorectal Neoplasms (Colorectal Cancer)
10/2007 - 06/2003
2
Neoplasm Metastasis (Metastasis)
10/2007 - 06/2003
1
Multiple Myeloma
01/2019
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1
Hodgkin Disease (Hodgkin's Disease)
10/2018
1
Lymphoma (Lymphomas)
10/2018
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2018
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2014
1
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2013
1
Breast Neoplasms (Breast Cancer)
05/2012
1
Cytokine Release Syndrome
02/2011
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2005
Drug/Important Bio-Agent (IBA)
11
Chimeric Antigen Receptors
IBA
10/2019 - 07/2012
6
Antigens
IBA
04/2018 - 07/2004
4
Cytokines
IBA
10/2018 - 10/2007
4
Proteins (Proteins, Gene)
FDA Link
01/2018 - 10/2007
4
CD19 Antigens
IBA
01/2017 - 05/2005
3
Ligands
IBA
01/2019 - 01/2017
3
Interleukin-2 (IL2)
IBA
08/2014 - 07/2008
3
Carcinoembryonic Antigen
IBA
10/2007 - 06/2003
2
Neoplasm Antigens (Tumor Antigens)
IBA
10/2019 - 04/2018
2
Antigen Receptors (Antigen Receptor)
IBA
01/2019 - 06/2003
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
10/2013 - 07/2012
2
Vaccines
IBA
05/2012 - 07/2004
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2008 - 05/2008
1
Nelfinavir (Viracept)
FDA Link
01/2020
1
HIV Protease Inhibitors
IBA
01/2020
1
Interleukin-12 (IL 12)
IBA
10/2018
1
Enzymes
IBA
10/2018
1
Immunosorbents
IBA
10/2018
1
Natural Killer Cell Receptors
IBA
08/2017
1
Tyrosine Kinase Inhibitors
IBA
08/2014
1
Sunitinib (Sutent)
FDA Link
08/2014
1
pazopanib
FDA Link
08/2014
1
Interleukin-15 (Interleukin 15)
IBA
10/2013
1
Interleukin-7 (Interleukin 7)
IBA
10/2013
1
Peptides (Polypeptides)
IBA
02/2011
1
fludarabine
IBA
05/2008
1
Alkylating Agents
IBA
01/2008
1
O(6)-Methylguanine-DNA Methyltransferase
IBA
01/2008
1
Chemokines
IBA
10/2007
1
Chemokine Receptors
IBA
10/2007
1
Interleukin-4 (Interleukin 4)
IBA
10/2007
1
Chemokine CCL24
IBA
10/2007
1
Interleukin-13
IBA
10/2007
1
Single-Chain Antibodies
IBA
05/2005
1
Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)
IBA
05/2005
1
Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)
IBA
07/2004
Therapy/Procedure
21
Therapeutics
10/2019 - 06/2003
8
Immunotherapy
01/2020 - 07/2004
3
Drug Therapy (Chemotherapy)
07/2008 - 01/2008
2
Cell- and Tissue-Based Therapy (Cell Therapy)
10/2013 - 06/2010